BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 37184402)

  • 1. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT.
    Shen M; Guo L; Zhang H; Zheng B; Liu X; Gu J; Yang T; Sun C; Yi X
    J Nanobiotechnology; 2024 Jun; 22(1):310. PubMed ID: 38831378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
    Zhou S; Cheng F; Zhang Y; Su T; Zhu G
    Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy.
    Li J; Han X; Gao S; Yan Y; Li X; Wang H
    J Nanobiotechnology; 2023 Oct; 21(1):382. PubMed ID: 37858171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Immunotherapy Based on Cell Membrane-Coated Nanocomposites Augmenting cGAS/STING Activation by Efferocytosis Blockade.
    Chen Z; Li Z; Huang H; Shen G; Ren Y; Mao X; Wang L; Li Z; Wang W; Li G; Zhao B; Guo W; Hu Y
    Small; 2023 Oct; 19(43):e2302758. PubMed ID: 37381095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
    Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
    Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
    Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy.
    Guo X; Tu P; Wang X; Du C; Jiang W; Qiu X; Wang J; Chen L; Chen Y; Ren J
    Adv Mater; 2024 May; 36(21):e2313029. PubMed ID: 38353366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
    Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
    Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
    Shen Q; Xu P; Mei C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
    Pépin G; Gantier MP
    Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
    Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
    J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-based nano-micelles for potential anti-tumor immunotherapy: Synergistic effect of cGAS-STING signaling pathway activation and tumor antigen absorption.
    Zhang S; Zeng Y; Wang K; Song G; Yu Y; Meng T; Yuan H; Hu F
    Carbohydr Polym; 2023 Dec; 321():121346. PubMed ID: 37739513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
    Guo J; Huang L
    Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
    Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
    Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotropic roles of cGAS-STING signaling in the tumor microenvironment.
    Li J; Bakhoum SF
    J Mol Cell Biol; 2022 Aug; 14(4):. PubMed ID: 35325182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Radiosensitization Nanoagent to Activate cGAS-STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy.
    Wu Z; Li Q; Zhu K; Zheng S; Hu H; Hou M; Qi L; Chen S; Xu Y; Zhao B; Yan C
    Adv Healthc Mater; 2024 Jun; 13(14):e2303626. PubMed ID: 38387885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.